A Plus Biotechnology Co., Ltd. (TPE:6918)

Market Cap	2.71B -10.6%
Revenue (ttm)	835.89M +8.6%
Net Income	169.38M +12.1%
EPS	5.15 +3.6%
Shares Out	33.70M
PE Ratio	15.61
Forward PE	n/a
Dividend	5.00 (6.22%)
Ex-Dividend Date	Mar 27, 2026

Volume	60,461
Average Volume	51,372
Open	82.00
Previous Close	80.00
Day's Range	80.10 - 82.00
52-Week Range	78.00 - 136.00
Beta	0.05
RSI	39.16
Earnings Date	May 11, 2026

About A Plus Biotechnology

A Plus Biotechnology Co., Ltd. engages in the manufacturing and wholesale of orthopedic and other medical devices. The company offers products for chest, shoulder, spine, elbow, wrist and hand, pelvic and hip, knee, foot and ankle, osteotomy, pediatric and ESF, biologics. It also provides bone grafts. A Plus Biotechnology Co., Ltd. was founded in 2009 and is based in New Taipei City, Taiwan.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2009
• Country: Taiwan
• Stock Exchange: Taiwan Stock Exchange
• Ticker Symbol: 6918

Financial Performance

In 2025, A Plus Biotechnology's revenue was 835.89 million, an increase of 8.61% compared to the previous year's 769.59 million. Earnings were 169.38 million, an increase of 12.13%.